CSF2 and breast carcinoma: In breast cancer, granulocyte-macrophage colony stimulating factor (GM-CSF) derived from the inflammatory microenvironment enhanced PD-L1 expression on TAMs and inhibited T-cell activation by activating the STAT3 pathway (91).